Latest Content

According to Raphael Rostenne, CTO of EyeCarePro, "anything that takes time" has the potential to frustrate patients, especially before they're in a practitioner's chair.

Now on EYE7 smart glasses, Eva goes beyond answering questions by reasoning about user needs and controlling vision-enhancement features.

Kansas, Tennessee, and Vermont expanded optometric scope in 2026, while vision plan reform and a proposed Medicare fee schedule cut affect practice management.

Bita Asghari, OD, FAAO, FSLS, discusses diagnosing ocular surface inflammation, recognizing atypical keratitis, and knowing when to refer to a cornea specialist.

The approval followed complete response letters tied to inspection and manufacturing issues.

What to take away on PBM, hormonal eye health, and GLP-1 receptor agonists from this year’s meeting.

Host Hamza Shah, OD, MS, FAAO, is joined by Melissa Barnett, OD, FAAO, FSLS, FBCLA, to discuss burnout among US optometrists, inspired by Abbott et al's nationwide survey.

From treating myopic complications to preventing them, eye care providers have ample opportunity to close a collaborative care gap.

This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.

The licaminlimab trial enrolled 176 patients, two-thirds with a TNFR1 variant tied to stronger response. Data expected late 2026.

Nicole Haessly, OD, FAAO, discusses common unsafe contact lens habits, overlooked care steps, and how lens innovations have improved safety.

Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her performance vision evaluations.

FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites.